Get started
Author

Anthony Hadla

Observed name: Hadla, Anthony
ORCID: 0000-0003-4668-9408
Observed ORCID: 0000-0003-4668-9408
OpenAlex ID: A5022322795
A risk-reward examination of sample multiplexing reagents for single cell RNA-Seq
2024 · Daniel V. Brown, Casey J.A. Anttila, et al. · Genomics · 26
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2022 · Gwo Yaw Ho, Elizabeth L. Kyran, et al. · Cancer Research · 26
PDF
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma
2026 · Andrew Farrell, Genevieve Dall, et al. · Journal of Experimental & Clinical Cancer Research · 2
Additional file 2 of High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma
2026 · Farrell, Andrew, Dall, Genevieve, et al. · Figshare
Additional file 1 of High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma
2026 · Farrell, Andrew, Dall, Genevieve, et al. · Figshare
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma
2026 · Farrell, Andrew, Dall, Genevieve, et al. · Figshare
Investigating novel treatment options for ovarian carcinosarcoma
2026 · Hadla, Anthony · Minerva Access (University of Melbourne)
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2025 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2025 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023 · Gwo Yaw Ho, Elizabeth L. Kyran, et al.
Works count: 20
Citation count: 54
H-index: 2
I10-index: 2
Year
Topic
Type